| 000 | 01267 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513191049.0 | ||
| 264 | 0 | _c19991007 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0268-4705 | ||
| 024 | 7 |
_a10.1097/00001573-199907000-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlazing, M A | |
| 245 | 0 | 0 |
_aEvidence supporting secondary prevention strategies. _h[electronic resource] |
| 260 |
_bCurrent opinion in cardiology _cJul 1999 |
||
| 300 |
_a303-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCoronary Disease _xcomplications |
| 650 | 0 | 4 | _aEstrogen Replacement Therapy |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipidemias _xdrug therapy |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aLife Style |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aO'Connor, C M | |
| 773 | 0 |
_tCurrent opinion in cardiology _gvol. 14 _gno. 4 _gp. 303-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001573-199907000-00005 _zAvailable from publisher's website |
| 999 |
_c10406318 _d10406318 |
||